Found 4 matching trials
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) PHASE1 This is a randomized, open label, multicenter trial to evaluate the safety,...
Show More Status
Active Not Recruiting
Location
University of Alabama Birmingham
Learn More & Join Trial
Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer PHASE1 This dose escalation study will determine a maximum tolerated dose and/or o...
Show More Location
University of Alabama Birmingham Cancer Center
Learn More & Join Trial
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer PHASE3 This is a randomized, adaptive, open label, multicenter trial to evaluate t...
Show More Learn More & Join Trial
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer PHASE1 This is a 1:1 randomized, open label, multi-center phase I/II trial to eval...
Show More Location
Johns Hopkins Medicine SKCCC
Learn More & Join Trial